Navigation Links
Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
Date:7/23/2008

slation that will give our intelligence professionals critical long-term authorities to monitor foreign intelligence targets located overseas. Earlier this week, I called upon Congress to take another step by passing legislation to address the questions about detainees unresolved by the Supreme Court's recent decision in Boumediene v. Bush. Congress and the Executive Branch are in a better position than the courts to create practical procedures and rules to govern the habeas corpus hearings required by the Supreme Court, procedures and rules that would both give the detainees what process they are due and accommodate the grave national security concerns involved. In my speech earlier this week, I outlined six principles that should guide such legislation, and I look forward to working with you and your colleagues on both sides of the aisle and in both houses of Congress to address these important issues promptly.

Second, as everyone knows, the election season is upon us. Although state and local governments have primary responsibility for administering elections, the Justice Department must make every effort to help assure that the elections run as smoothly as possible - and, equally important, that the American people have confidence in our electoral process.

The Department will maintain a significant presence throughout the election season through both outreach and monitoring. We will work closely with civil rights groups and state and local elections officials to identify and solve problems. We will publicize telephone numbers and websites through which people can bring potential issues to our attention. And, on Election Day, we will deploy hundreds of observers and monitors around the country.

These steps will supplement our ongoing efforts both to enforce laws, including the Voting Rights Act, designed to guarantee access of all Americans to the ballot and to enforce laws, including those prohibiting voter fraud and campaign finance abuse,
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
2. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
3. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
4. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
5. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
6. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
7. Allegheny General Hospital Performs First Liver Transplant
8. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
9. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
10. New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
11. New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...GO, Dec. 1 TargeGen has announced ... from a multi-center, US-based clinical,trial of ...s been scheduled at,the 2008 American Society of ...e presentation are as follows:, Title: ...available, JAK2-Selective ...
(Date:12/1/2008)...rl with Hypophosphatasia Treated With ENB-0040 at ...nipeg , , MONTREAL, Dec. 1 ...y focused on developing novel therapeutics for ser...t infant patient in its clinical program for hypop...yme Replacement Therapy (ERT) with ENB-0040 for th...
(Date:12/1/2008)...H MEETING, Pa., Dec. 1 ...ced that dosing of subjects has begun in study MSI...e Phase 1b study of trodusquemine (MSI-1436) in ov... novel therapeutic for the treatment of type 2 dia...erally to regulate insulin and leptin pathways thr...
(Date:12/1/2008)..., Dec. 1 GeoVax Labs, In...iotechnology company developing,human vaccines fo... Virus) and,other infectious agents, announced to... Trials will take place in twelve sites across Nor...in collaboration with The National Institutes of,...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Key to longer life 28in flies 29 lies in just 14 brain cells 1696 1Key to longer life 28in flies 29 lies in just 14 brain cells 1696 2Smart insulin nanostructures pass feasibility test UT study reports 1692 1Smart insulin nanostructures pass feasibility test UT study reports 1692 2Penn Veterinary Medicine report new strategy to create genetically modified animals 474 1Penn Veterinary Medicine report new strategy to create genetically modified animals 474 2UCSD study reveals the regulatory mechanism of key enzyme 1684 1UCSD study reveals the regulatory mechanism of key enzyme 1684 2
...ESS WIRE)--Jun 8, 2007 - Archemix Corp., a,biotech...ng,aptamers, announced the successful completion o..., ARC1779. ARC1779 is designed to,selectively bloc...elets by inhibiting the binding of von Willebrand ...tivated vWF is scientifically,recognized as the fi...
...NESS WIRE)--Jun 8, 2007 - NuPathe Inc., a,privatel...ounced,positive results from an initial Phase I st...ute migraine being developed,by NuPathe., NP101 co...phoretic transdermal technology with sumatriptan, ...raine in the United,States. Sumatriptan is also th...
Other Medicine Technology:Archemix Announces Completion of Phase 1 Trial of ARC1779 2Archemix Announces Completion of Phase 1 Trial of ARC1779 3NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 3
(Date:12/1/2008)...esses common, study shows , , MONDAY, D...e common among young adults in the United States, ...o reach this finding, U.S. researchers analyzed da..., who took part in the National Epidemiologic Surv...dy found that 45.8 percent of the 2,188 college st...
(Date:12/1/2008)...oundation announces the 2008 winners of the Lee C....ecipients, Dr. Gerard Karsenty of the Columbia Uni...nzweig of Rockefeller University received the awar... cure and control of rheumatic diseases. , Dr. ...elopment and function of the skeletal system. A gr...
(Date:12/1/2008)...all/ -- Senetek PLC,(OTC Bulletin Board: SNKTY), ...t of technologies that target the science of healt... specialists in the fields of strategic,developme...ices in Zurich,Bern and Geneva has published a R...ch Report, available in the "Investors" section of...
(Date:12/1/2008)...D) affects as many as one in five of all Americans...ault, war or terrorism. It has emotionally paralyz...lies. , There is no broadly accepted treatment ...er, but thanks to a Tel Aviv University researcher...round the corner. , Prof. Joseph Zohar from the ...
Breaking Medicine News(10 mins):Health News:Few Young Adults Seek Treatment for Psych Disorders 2Health News:Easing the stress of trauma 2
...nt under mandatory isolation since his Greek weddi...erious strain of the disease than initially thoug...ding travels, including seven flights and an overl...obal health alert two months ago when the US Cente...
...s hierarchy issued a decree on the state MENA news...as un-Islamic as the authorities prepared to submi...m of excision is a practice totally banned by Isla... of the extensive damage it causes to women's bodi...
...risers and cosmetic surgery, a compound found in t... skin. In the first study of its kind, a team of...ersity of East Anglia and Dr Paul Kroon at the Ins...hether the skins condition is improved by a compou...
...in northeast France are being analysed to see if t... be fatal to humans, the agriculture ministry said...icion of bird flu. More tests are under way to see...ction with the H5N1 strain,' the ministry said. R...
Other Medicine News:Health News:US Traveler With Deadly TB Has Less Serious Strain 2
...coma Laser System features a patented technique fo...-angle glaucoma. It selectively targets pigmented ...ular pressure. The Selecta II is equipped with a Q...eam of light, which induces the same cell replacem...
Round handle.
Angled shafts, smooth jaws, polished finish.
...signed for insertion of Alcon Acrylic, Chiron/Iola...lenses. The blades are taller and thinner, maximiz... feature prevents lens migration during loading an... spot on the folded lens optic. The special direct...
Medicine Products: